Parexel has announced its financial results for the third quarter of FY16, which remained strong in spite of the complexities associated with smaller clinical trials.
Quintiles and IMS Health have merged to form Quintiles IMS Holdings, effectively creating one of the world’s largest healthcare information portfolios.
Quintiles and Covance have re-iterated previous CROs’ upbeat stances on the prospect for further pharma M&A as they both reported revenue growth for the quarter.
Parexel posted a doubling in cancellations in Q3 of its fiscal year, with profits remaining flat as an eight per cent boost in service revenue was offset by higher operating expenses.
Troubled contract research organisation Encorium Group finally published its delayed financial results yesterday, posting a net loss of $3.9m, three times the year-earlier loss.
Troubled contract sales and marketing firm PDI has recently won a
much-needed new sales contract and made two new top executive
appointments as part of ongoing efforts to turn its flagging
business around.
